rs62074378

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001366385.1(CARD14):​c.1371G>A​(p.Ser457Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0416 in 1,608,020 control chromosomes in the GnomAD database, including 1,584 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S457S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.031 ( 101 hom., cov: 32)
Exomes 𝑓: 0.043 ( 1483 hom. )

Consequence

CARD14
NM_001366385.1 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.07

Publications

0 publications found
Variant links:
Genes affected
CARD14 (HGNC:16446): (caspase recruitment domain family member 14) This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012]
CARD14 Gene-Disease associations (from GenCC):
  • familial pityriasis rubra pilaris
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • psoriasis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 17-80195205-G-A is Benign according to our data. Variant chr17-80195205-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 458086.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.07 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0312 (4752/152242) while in subpopulation NFE AF = 0.0462 (3141/67990). AF 95% confidence interval is 0.0448. There are 101 homozygotes in GnomAd4. There are 2276 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 4752 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD14NM_001366385.1 linkc.1371G>A p.Ser457Ser synonymous_variant Exon 13 of 24 ENST00000648509.2 NP_001353314.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD14ENST00000648509.2 linkc.1371G>A p.Ser457Ser synonymous_variant Exon 13 of 24 NM_001366385.1 ENSP00000498071.1 Q9BXL6-1

Frequencies

GnomAD3 genomes
AF:
0.0313
AC:
4755
AN:
152124
Hom.:
102
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00922
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0300
Gnomad ASJ
AF:
0.0291
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0343
Gnomad FIN
AF:
0.0390
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0462
Gnomad OTH
AF:
0.0335
GnomAD2 exomes
AF:
0.0339
AC:
8355
AN:
246688
AF XY:
0.0350
show subpopulations
Gnomad AFR exome
AF:
0.00947
Gnomad AMR exome
AF:
0.0181
Gnomad ASJ exome
AF:
0.0365
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0373
Gnomad NFE exome
AF:
0.0474
Gnomad OTH exome
AF:
0.0361
GnomAD4 exome
AF:
0.0427
AC:
62161
AN:
1455778
Hom.:
1483
Cov.:
31
AF XY:
0.0425
AC XY:
30760
AN XY:
723478
show subpopulations
African (AFR)
AF:
0.00901
AC:
301
AN:
33394
American (AMR)
AF:
0.0191
AC:
852
AN:
44552
Ashkenazi Jewish (ASJ)
AF:
0.0346
AC:
901
AN:
26054
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39602
South Asian (SAS)
AF:
0.0335
AC:
2882
AN:
86040
European-Finnish (FIN)
AF:
0.0376
AC:
1951
AN:
51824
Middle Eastern (MID)
AF:
0.0372
AC:
190
AN:
5106
European-Non Finnish (NFE)
AF:
0.0476
AC:
52828
AN:
1109074
Other (OTH)
AF:
0.0374
AC:
2251
AN:
60132
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
3337
6673
10010
13346
16683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1944
3888
5832
7776
9720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0312
AC:
4752
AN:
152242
Hom.:
101
Cov.:
32
AF XY:
0.0306
AC XY:
2276
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.00920
AC:
382
AN:
41542
American (AMR)
AF:
0.0300
AC:
458
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
101
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0337
AC:
163
AN:
4832
European-Finnish (FIN)
AF:
0.0390
AC:
414
AN:
10612
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0462
AC:
3141
AN:
67990
Other (OTH)
AF:
0.0331
AC:
70
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
239
478
716
955
1194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0279
Hom.:
31
Bravo
AF:
0.0294
Asia WGS
AF:
0.0150
AC:
54
AN:
3478
EpiCase
AF:
0.0458
EpiControl
AF:
0.0491

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pityriasis rubra pilaris;C1864497:Psoriasis 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Jan 22, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.1
DANN
Benign
0.41
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62074378; hg19: chr17-78169004; API